Next gen quantitative mass spec launches at ASMS 2024
5 Jul 2024
Dr. August Specht, VP of R&D, Chromatography and Mass Spec division at Thermo Fisher Scientific, highlights the company’s innovative new mass spectrometry instrument, the Stellar™ Mass Spectrometer. The instrument was launched alongside a range of other pioneering new products at ASMS 2024.
The Stellar MS focuses on quantitation at scale, specifically targeting high volume peptide quantitation. In this interview, Specht outlines how the instrument perfectly accompanies Thermo Fisher Scientific’s Orbitrap Astral Mass Spectrometer, launched last year, which focuses on discovery experiments at scale with incredible sensitivity, while the Stellar MS drives forward the quantitation field.
This video was filmed at ASMS 2024. Explore our full coverage of this year's conference >>
About the company
Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
